Felbinac
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
biphenyl-4-ylacetic acid
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | |
Routes of administration |
Topical |
Identifiers | |
CAS Number | 5728-52-9 |
ATC code | M02AA08 (WHO) |
PubChem | CID: 3332 |
DrugBank | DB07477 ![]() |
ChemSpider | 3215 ![]() |
UNII | 94WNJ5U8L7 ![]() |
KEGG | D01675 ![]() |
ChEBI | CHEBI:31597 ![]() |
ChEMBL | CHEMBL413965 ![]() |
Chemical data | |
Formula | C14H12O2 |
Molecular mass | 212.244 g/mol |
|
|
|
|
(verify) |
Felbinac (INN, or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) of the arylpropionic acid class, which is used to treat muscle inflammation and arthritis. It is an active metabolite of fenbufen.[1]
Footnotes
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
References
- The Merck Index, 12th Edition. 3989
- Description of Felbinac on Tiscali [1]
<templatestyles src="Asbox/styles.css"></templatestyles>